about
Endocrine causes of nonalcoholic fatty liver disease'Micro-managers' of hepatic lipid metabolism and NAFLDIncretin based therapies: a novel treatment approach for non-alcoholic fatty liver diseaseAlanine aminotransferase-old biomarker and new concept: a reviewThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Recent Advances in the Treatment of NASH.Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model.T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse.Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adultsAssociation between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.Association between diabetes mellitus with metabolic syndrome and diabetic microangiopathy.Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsNew clinical score to diagnose nonalcoholic steatohepatitis in obese patients.The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.Real-time histology in liver disease using multiphoton microscopy with fluorescence lifetime imaging.Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver.Non-alcoholic fatty liver disease: The diagnosis and management.Mortality from cirrhosis: lack of progress over the last 35 years.Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in miceThe role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitisHyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigsPeripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients.A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apneaEffects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expressionBariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?Steatosis as a risk factor in liver surgery.Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C.Predictive factors for the development or regression of Fatty liver in Japanese adults.Nonalcoholic fatty liver disease: from clinical recognition to treatment.Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of TaiwanBL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress.Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.
P2860
Q26780254-A679D58F-9B54-4FEE-9EF8-784BBB480E93Q26801228-D803D783-AB9D-4127-89CD-A04B8A5B36DBQ26827183-972C291A-3719-4977-9C0C-31E2BD6E4BAFQ26828819-348EFC25-FDC5-44DB-94A6-4D609EA6A8E7Q27008277-B89D720A-861B-41A6-BBA2-45952E480DF8Q30354081-1FD687ED-C0F5-486B-9860-883273CF2013Q33520636-32E880CD-698E-4A33-B5CE-C15F06090FE2Q33633689-FBBF7938-429A-49E8-B81A-775331CEC9FFQ33675416-4BC7AD0A-42E1-4FBB-B933-5A1FE6D3B88EQ33857534-91D1C7AE-DCB7-4528-A54E-E4629858E13EQ34086356-B439B811-E41F-42DF-B799-11E566CEE23FQ34112196-F71A8425-73E1-4527-B86F-5D2F7741453FQ34222246-55B01C1B-22D1-4A51-A42C-4383CA75C358Q34303169-FC125EFD-8FDB-4067-9EA3-416569E4422DQ34443979-8A660CB7-DF69-4B9B-834A-90D3B7A159A0Q34446294-FA52CFFB-6062-4678-BEB5-11431A860FE3Q34662500-952BC2EB-61FA-4C2D-A7B8-FFBA4A8262CCQ35090416-A5030E8A-454E-4831-BCA1-671DED38DED6Q35181761-7FB3F56B-FD95-409B-8506-68454634DF1FQ35522423-7A8CCB1F-277E-4E8C-9FF9-F3CCCBF207E1Q35543956-96153384-5A04-4CEB-AE0D-2DE963892DA6Q35597854-DFB9B4D8-AD7A-4A15-905C-341375D5ED88Q35626493-4BBB22EC-6064-4696-A95D-794B30D29B00Q35761434-E82B5E87-00F8-41FC-BE3D-83FB062D1C82Q36049336-80AFDA7F-59F0-4300-8AA5-70CD5166D272Q36085542-2E61E912-B7F1-470A-A5FC-24642AB2C559Q36172470-A200F7D8-4B70-4974-B337-C437D8CD07D7Q36194038-A7128E41-C956-4FE3-A1CB-29C22BBBFD92Q36427028-D7C22AED-2905-4AC9-9C38-F048414CE07CQ36473631-8F68C32F-722D-4064-B1CB-EEE5EE467694Q36602895-18F91836-A598-43B4-B3EC-D1CADA965BFAQ36696488-67D8346D-6D5F-48EB-9B9F-6B02182638CAQ36788693-E7FDA555-C97E-4085-A8DA-9AB76ABCCCB8Q36983260-9FF17174-7082-4322-BD35-64D11ED488BCQ37246806-540CF0B3-99F4-437B-8957-63D783EE6AF3Q37345907-30BB728E-23CE-4D2B-90B8-7D4E58B28186Q37599777-E0EBA952-ADD4-41AE-81E1-58AFEEB27521Q37676026-556FF631-CE43-43AA-A012-B34393EA083EQ37719108-D52F7CD2-63F7-48FF-A632-E69EDDA95FA5Q37727871-6E8B55F0-9FB8-4884-9832-82037E55C6BC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nonalcoholic fatty liver disease: a clinical review.
@ast
Nonalcoholic fatty liver disease: a clinical review.
@en
type
label
Nonalcoholic fatty liver disease: a clinical review.
@ast
Nonalcoholic fatty liver disease: a clinical review.
@en
prefLabel
Nonalcoholic fatty liver disease: a clinical review.
@ast
Nonalcoholic fatty liver disease: a clinical review.
@en
P2093
P1476
Nonalcoholic fatty liver disease: a clinical review.
@en
P2093
David A Sass
Kapil B Chopra
Parke Chang
P2888
P304
P356
10.1007/S10620-005-1267-Z
P577
2005-01-01T00:00:00Z